Peter Stazzone insider trades
Open-market stock purchases and sales by Peter Stazzone, Chief Financial Officer at Lixte Biotechnology Holdings, Inc, from SEC Form 4 filings since Sep 1, 2025.
Companies traded
- LIXT Lixte Biotechnology Holdings, Inc: other filings, last Jul 1, 2026